Pharmaceutical products for the treatment of neurological diseases and disorders; pharmaceutical products for the treatment of autoimmune diseases and disorders; pharmaceutical products for the treatment of multiple sclerosis (MS); pharmaceutical products for the treatment of relapsing forms of multiple sclerosis (MS); pharmaceutical products for the treatment of clinically isolated syndrome; pharmaceutical products for the treatment of relapsing-remitting multiple sclerosis (MS) disease; pha...